InvestorsHub Logo
Followers 152
Posts 7471
Boards Moderated 1
Alias Born 04/04/2006

Re: None

Sunday, 01/16/2022 9:17:38 AM

Sunday, January 16, 2022 9:17:38 AM

Post# of 198924
"In addition to announcing these plans to begin the production of Enzolytics IPF Immune™, the Company has engaged a national marketing and branding agency as its distributor to advance the product through multiple distribution channels throughout the U.S. The Company will significantly benefit from the extensive capacity of the agency to place this product in major outlets, large and small, throughout the country. In addition, the marketing agency’s long-stating presence and capability in the industry is a significant benefit to the Company. According to Grand View Research, the North American dietary supplements market was $50.11 Billion in 2020, and the revenue forecast in 2028 is estimated at $77.1 Billion. This year-over-year increase has led to record sales of immunity-enhancing supplements. In 2020, immunity-boosting supplements had record sales, making up one-third of all new supplements sales. "

https://www.einpresswire.com/article/560014946/enzolytics-ipf-immune-helps-fight-infections

On Jan 6th, 2022, Nutritional Products International, Inc. published an article featuring Enzolytics IPF Immune??, confirming North America Distribution and products available in the US soon.